We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Strain of Mad Cow Disease Found

By Biotechdaily staff writers
Posted on 01 Mar 2004
In a new study, Italian researchers have identified what appears to be a new strain of prion disease, similar to mad cow disease. More...
The study was published in the February 17, 2004 issue of the Proceedings of the [U.S.] National Academy of Sciences.

The brains of two cows infected with this new strain were found to look much like the human brains of people with sporadic Creutzfeldt-Jakob disease (CJD), which has not been linked to tainted meat or bovine spongiform encephalopathy (BSE), known as mad cow disease. What has been linked to BSE is new variant (nv) CJD, which has occurred in humans. In fact, around 150 cases of nvCJD have occurred in the United Kingdom, all associated with eating cattle infected with BSE.

The Italian scientists call the new strain bovine amyloidotic spongiform encephalopathy (BASE). This strain appeared in much older cattle, and the prions collected in the olfactory bulb and thalamus instead of in the brain stem. The scientists believe that eating meat with this new strain could produce CJD in people. Current U.S. tests used to find the prions that cause BSE in cows and nvCJD in people may not be able to identify the new strain. Meanwhile, other recent reports of differing types of mad cow disease in Japan and France suggest that many cases diagnosed as sporadic may instead be the result of eating animals with BSE.

The study was led by Dr. Salvatore Monaco and Dr. Gianluigi Zanusso, of the University of Verona (Italy), and was edited by Dr. Stanley Prusiner, awarded a Nobel Prize in 1977 for his work on prions.




Related Links:
University of Verona

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.